
Investornewsbreaks Prophase Labs Inc. (NASDAQ: PRPH) Closes $23.6M Sale To Focus On Core Businesses
(MENAFN- Investor Brand Network) ProPhase (NASDAQ: PRPH) , a next-generation biotech, genomics, and diagnostics company, earlier this year announced the closing of the sale of its wholly owned subsidiaries, Pharmaloz Manufacturing Inc. and Pharmaloz Real …